|
Lotronex Information
FDA announced June 7, 2002 the approval of a supplemental
New Drug Application (sNDA) that allows restricted marketing of Lotronex (alosetron
hydrochloride), to treat only women with severe diarrhea-predominant
irritable bowel syndrome (IBS). The approved sNDA for Lotronex includes a
risk management program to ensure patients and physicians are fully informed of risks
and possible benefits of Lotronex.
Do Not Buy Lotronex Over the
Internet
- You should not buy Lotronex over the Internet because you
will bypass important safeguards designed to protect your
health (and the health of others).
- Lotronex has special safety restrictions on how it is
distributed to the public. Also, drugs purchased from foreign
Internet sources are not the FDA-approved versions of the
drugs, and they are not subject to FDA-regulated manufacturing
controls or FDA inspection of manufacturing facilities.
To learn more about buying drugs safely, please see
|
Current Lotronex Information
Background Lotronex Information
Back to Top
Back to Drug Info
FDA/Center for Drug Evaluation and Research
Last Updated: December 16, 2002
Originator: OTCOM/DLIS
HTML by SJW |